Lv41
414 积分 2021-10-08 加入
DARK AND BRIGHT SIDE OF TARGETING THE FIBROBLAST GROWTH FACTOR RECEPTOR 4 IN THE LIVER
3小时前
待确认
SEPTIN7 Enhances Tumorgenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
2天前
已完结
SEPTIN7 Enhances Tumorgenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
7天前
已完结
Targeting cholesterol esterification sensitizes liver cancer to CD8+ T cell attack by impairing metabolic and redox resilience
25天前
已完结
Insight into the design of FGFR4 selective inhibitors in cancer therapy: Prospects and challenges
26天前
已完结
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
2个月前
已完结
Differential therapeutic implications of the OSM-OSMR signaling pathway in cancer and inflammatory diseases
2个月前
已完结
Discovery of Novel MLKL PROTAC Degraders for the Treatment of Hepatocellular Carcinoma via Promoting Parthanatos
3个月前
已完结
A sulfated pectin polysaccharide from Chrysanthemum morifolium induces ferroptosis in pancreatic cancer by stabilizing TFRC
3个月前
已完结
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
4个月前
已完结
皖公网安备34019202002308
